PL3365684T3 - Sposób wzbogacania nukleosomów pozakomórkowych - Google Patents

Sposób wzbogacania nukleosomów pozakomórkowych

Info

Publication number
PL3365684T3
PL3365684T3 PL16787545T PL16787545T PL3365684T3 PL 3365684 T3 PL3365684 T3 PL 3365684T3 PL 16787545 T PL16787545 T PL 16787545T PL 16787545 T PL16787545 T PL 16787545T PL 3365684 T3 PL3365684 T3 PL 3365684T3
Authority
PL
Poland
Prior art keywords
nucleosomes
enriching extracellular
enriching
extracellular
extracellular nucleosomes
Prior art date
Application number
PL16787545T
Other languages
English (en)
Inventor
Jacob Vincent Micallef
Mark Edward Eccleston
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Publication of PL3365684T3 publication Critical patent/PL3365684T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/12Post-translational modifications [PTMs] in chemical analysis of biological material alkylation, e.g. methylation, (iso-)prenylation, farnesylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL16787545T 2015-10-21 2016-10-21 Sposób wzbogacania nukleosomów pozakomórkowych PL3365684T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1518665.3A GB201518665D0 (en) 2015-10-21 2015-10-21 Method for enrichment of cell free nucleosomes
PCT/GB2016/053305 WO2017068371A1 (en) 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes
EP16787545.9A EP3365684B1 (en) 2015-10-21 2016-10-21 Method for the enrichment of cell free nucleosomes

Publications (1)

Publication Number Publication Date
PL3365684T3 true PL3365684T3 (pl) 2021-05-04

Family

ID=55131411

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16787545T PL3365684T3 (pl) 2015-10-21 2016-10-21 Sposób wzbogacania nukleosomów pozakomórkowych

Country Status (12)

Country Link
US (2) US10746746B2 (pl)
EP (2) EP3798634A1 (pl)
JP (1) JP6831841B2 (pl)
CN (1) CN108603884A (pl)
AU (1) AU2016341501B2 (pl)
CA (1) CA3002505A1 (pl)
DK (1) DK3365684T3 (pl)
ES (1) ES2830800T3 (pl)
GB (1) GB201518665D0 (pl)
PL (1) PL3365684T3 (pl)
SG (1) SG11201803161YA (pl)
WO (1) WO2017068371A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1206055A1 (en) 2012-03-02 2015-12-31 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
HK1216655A1 (zh) 2013-03-13 2016-11-25 Sequenom, Inc. 用於dna甲基化分析的引物
US11365447B2 (en) 2014-03-13 2022-06-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2913665T3 (es) * 2017-09-18 2022-06-03 Santersus Ag Método y dispositivo para la purificación de sangre a partir de ADN celular libre en circulación
AU2019228625B2 (en) 2018-03-01 2024-11-07 Epicypher, Inc. Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
CN112119166B (zh) * 2018-03-13 2025-08-22 耶路撒冷希伯来大学伊萨姆研发有限公司 无细胞dna染色质免疫沉淀的诊断应用
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
GB201906199D0 (en) * 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
EP3757227A1 (en) * 2019-06-25 2020-12-30 Aarhus Universitet Cell-free chromatin immunoprecipitation (cfchip) as a measure of tumour gene expression in a sample
JP2022545821A (ja) * 2019-08-27 2022-10-31 ベルジアン ボリション エスアールエル 循環ヌクレオソームを単離する方法
GB201912251D0 (en) 2019-08-27 2019-10-09 Belgian Volition Sprl Method of isolating circulating nucleosomes
PL4070111T3 (pl) * 2019-12-02 2025-02-03 Belgian Volition Srl Zastosowanie wolnych pozakomórkowych nukleosomsów jako biomarkerów
TW202242145A (zh) * 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
WO2024042210A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
GB202300607D0 (en) 2023-01-16 2023-03-01 Belgian Volition Srl Proteins and methods for isolating circulating nucleosomes
WO2025073909A1 (en) 2023-10-04 2025-04-10 Belgian Volition Srl Pcr method for detecting ctcf occupied cfdna fragments
CN117904196B (zh) * 2024-01-05 2024-07-12 安徽大学 一种非小细胞肺癌组蛋白h1.4赖氨酸乙酰化点突变细胞模型的构建及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
GB0319376D0 (en) 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
LT3783110T (lt) 2009-11-05 2023-01-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
US9096655B2 (en) 2010-01-27 2015-08-04 Tata Memorial Centre Method for in-vivo binding of chromatin fragments
US8981066B2 (en) 2011-08-23 2015-03-17 Buck Institute For Research On Aging Epigenetic mechanisms related to DNA damage and aging
GB201115099D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
CN104067125B (zh) * 2011-12-07 2017-12-26 比利时意志有限责任公司 用于检测核小体加合物的方法
HK1206055A1 (en) * 2012-03-02 2015-12-31 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations

Also Published As

Publication number Publication date
US20200340997A1 (en) 2020-10-29
US20190064184A1 (en) 2019-02-28
EP3798634A1 (en) 2021-03-31
DK3365684T3 (da) 2020-12-21
EP3365684B1 (en) 2020-09-23
SG11201803161YA (en) 2018-05-30
AU2016341501B2 (en) 2022-09-08
WO2017068371A1 (en) 2017-04-27
ES2830800T3 (es) 2021-06-04
AU2016341501A1 (en) 2018-05-10
EP3365684A1 (en) 2018-08-29
GB201518665D0 (en) 2015-12-02
CN108603884A (zh) 2018-09-28
JP6831841B2 (ja) 2021-02-17
US10746746B2 (en) 2020-08-18
JP2019500582A (ja) 2019-01-10
CA3002505A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
PL3365684T3 (pl) Sposób wzbogacania nukleosomów pozakomórkowych
IL249981A0 (en) Method
PL3092124T3 (pl) Sposób wytwarzania fornirowanego elementu
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
LT3137169T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
IL245356A0 (en) Method and system of automated generation of user form interface
LT3160956T (lt) Lizinui specifinės demetilazės-1 inhibitoriai
LT3164380T (lt) Lizinui specifiniai demetilazės-1 inhibitoriai
EP3287793A4 (en) AUTO ANALYZER AND METHOD
DK3132009T3 (da) Fremgangsmåde
IL248785A0 (en) Carboxamide derivatives
EP3368921A4 (en) MODIFICATION OF AN INTERACTIVE SALT MODEL
PL3169844T3 (pl) Sposób zapobiegania tworzeniu się kamienia kotłowego
IL252086A0 (en) Novel methods
PL3131549T3 (pl) Sposób leczenia zaburzeń ruchowych przy użyciu befiradolu
IL248739B (en) Method of displaying images
LT3152325T (lt) Trišakės neuralgijos diagnostikos būdas
PL3161136T3 (pl) Sposób wzbogacania mikropęcherzyków
LT3253772T (lt) Diosmino ruošimo būdas
PL3180295T3 (pl) Sposób szybkiej humifikacji i biostabilizacji
IL254336A0 (en) Novel treatment method
PL3410868T3 (pl) Sposób wytwarzania samoemulgującej kompozycji tłuszczowej
PL3283552T3 (pl) Sposób acetylacji ciągłej elementów drewnianych
DK3280699T3 (da) Fremgangsmåde til fremstilling af acylsulfamoylbenzamider
DK3053446T3 (da) Fremgangsmåde til fremstilling af schweizerost